Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.32.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HC.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HC.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HC.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.512ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.512ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.512NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.349ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.349ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.349ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.349NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.265ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.265ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.265ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.265NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.401ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.401ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.401ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.401NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.362ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.362ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.362ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.362NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FW.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FW.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.1.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used